Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

I.a

Pneumonitis (interstitial lung disease/ILD)

Publications

Watzal V, Godbersen GM, Weidenauer A, Willeit M, Popper V, Treiber M, Preiss M, Ivkic D, Rabl U, Fugger G, Frey R, Kraus C, Rujescu D, Bartova L

Case report: Interstitial pneumonitis after initiation of lamotrigine.

Frontiers in psychiatry 2023;14;1203497 — 2023 — 1203497

Madsen HD, Davidsen JR

[Lamotrigine-induced pneumonitis].

Ugeskrift for laeger 2016 Dec 12;178; — 2016 Dec 12

Saravanan N, Otaiku OM, Namushi RN

Interstitial pneumonitis during lamotrigine therapy.

British journal of clinical pharmacology 2005 Dec;60;666-7 — 2005 Dec — 666-7